🇺🇸 FDA
Patent

US 12144812

Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators

granted A61KA61K31/513A61K9/2009

Quick answer

US patent 12144812 (Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/513, A61K9/2009, A61K9/2013, A61K9/2027